Efficacy and Safety of Faldaprevir, Deleobuvir, and Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C Virus Infection and Advanced Liver Fibrosis or Cirrhosis

Patients with advanced hepatic fibrosis or cirrhosis with chronic hepatitis C virus (HCV) infection represent an unmet need. The HCV NS3/4A inhibitor, faldaprevir, was evaluated in combination with the nonnucleoside NS5B inhibitor, deleobuvir, with or without ribavirin in treatment-naive patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Zeuzem, Stefan, Soriano, Vicente, Asselah, Tarik, Gane, Edward J., Bronowicki, Jean-Pierre, Angus, Peter, Lohse, Ansgar W., Stickel, Felix, Müllhaupt, Beat, Roberts, Stuart, Schuchmann, Marcus, Manns, Michael, Bourlière, Marc, Buti, Maria, Stern, Jerry O., Gallivan, John-Paul, Voss, Florian, Sabo, John P., Böcher, Wulf, Mensa, Federico J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335863/
https://ncbi.nlm.nih.gov/pubmed/25512403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04383-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados